Page last updated: 2024-09-02

selenomethylselenocysteine and Arteriosclerosis, Coronary

selenomethylselenocysteine has been researched along with Arteriosclerosis, Coronary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blankenberg, S; Handy, DE; Lackner, KJ; Loscalzo, J; Lubos, E; Messow, CM; Munzel, T; Peetz, D; Schnabel, R; Sinning, CR; Wild, PS; Zeller, T1

Trials

1 trial(s) available for selenomethylselenocysteine and Arteriosclerosis, Coronary

ArticleYear
Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study.
    American heart journal, 2008, Volume: 156, Issue:6

    Topics: Aged; Antioxidants; Coronary Artery Disease; Coronary Vessels; Cysteine; Dose-Response Relationship, Drug; Endothelium, Vascular; Erythrocytes; Female; Glutathione Peroxidase; Humans; In Vitro Techniques; Male; Middle Aged; Organoselenium Compounds; Prospective Studies; Selenocysteine; Selenomethionine; Sodium Selenite; Vasodilation

2008